Primera bipartición del tránsito intestinal en el Instituto Mexicano del Seguro Social.

Saved in:

Bibliographic Details
Title:	Primera bipartición del tránsito intestinal en el Instituto Mexicano del Seguro Social.
Alternate Title:	First intestinal transit bipartition at the Mexican Institute for Social Security.
Authors:	Salazar-Rios, Enrique¹, Moro-Esperón, Alejandro¹, Hernández-Licona, Jennifer¹, Gutiérrez-Rojas, Carlos A.¹ laparoscopicaybariatrica@gmail.com
Source:	Revista Medica del IMSS. may/jun2026, Vol. 64 Issue 3, p1-7. 7p.
Subjects:	BARIATRIC surgery, SLEEVE gastrectomy, REDUCING diets, TYPE 2 diabetes, DEFICIENCY diseases, METABOLIC regulation, WEIGHT loss
Abstract (English):	Background: Obesity is a highly prevalent disease that significantly impacts quality of life and life expectancy. Over the past decades, bariatric surgery has become the gold standard for treating obesity and its comorbidities. In 2006, Santoro et al. described the technique of intestinal transit bipartition (ITB) to enhance neuroendocrine mechanisms of weight loss while minimizing nutritional deficiencies common in other procedures. The objective was to describe the first case of ITB performed in a high specialty center as a surgical treatment for obesity. Clinical case: A 44-year-old male patient with grade III obesity and comorbidities, including type 2 diabetes mellitus and obstructive sleep apnea. The patient underwent ITB combined with sleeve gastrectomy. During follow-up, a significant reduction in body weight was observed (%EWL of 94.9% at 6 months), without alterations in biochemical parameters such as albumin, hemoglobin, or vitamin D levels. The procedure was safe, with no surgical or postoperative complications. Conclusion: ITB is a promising surgical technique for the treatment of obesity and its comorbidities, with results comparable to other bariatric procedures. Its neuroendocrine effect favors metabolic control and significant weight loss, while limiting nutritional complications. Initial results highlight its safety and feasibility as a therapeutic alternative, although long-term studies are required to confirm its sustained impact on metabolic health. [ABSTRACT FROM AUTHOR]
Abstract (Spanish):	Introducción: la obesidad es una enfermedad de alta prevalencia que impacta significativamente la calidad y expectativa de vida. Durante las últimas décadas, la cirugía bariátrica se ha consolidado como el estándar de oro para tratar la obesidad y sus comorbilidades. En 2006, Santoro et al. describieron la técnica de bipartición del tránsito intestinal (BTI) para potenciar los mecanismos neuroendocrinos de pérdida de peso y minimizar las deficiencias nutricionales comunes en otros procedimientos. El objetivo fue describir el primer caso de BTI realizado en un centro de alta especialidad como tratamiento quirúrgico para la obesidad. Caso clínico: paciente de sexo masculino de 44 años con obesidad grado III y comorbilidades, incluida diabetes mellitus tipo 2 y apnea obstructiva del sueño. El paciente fue sometido a una BTI con manga gástrica. Durante el seguimiento, se observó una reducción significativa del peso corporal (%EWL del 94.9% a los 6 meses) sin alteraciones en los parámetros bioquímicos de albúmina, hemoglobina o vitamina D. El procedimiento fue seguro, sin complicaciones quirúrgicas o postoperatorias. Conclusión: la BTI es una técnica quirúrgica prometedora para tratar la obesidad y sus comorbilidades, con resultados comparables a otros procedimientos bariátricos. Su efecto neuroendocrino favorece un control metabólico y una pérdida de peso significativa, a la vez que limita las complicaciones nutricionales. Los resultados iniciales destacan su seguridad y viabilidad como alternativa terapéutica, aunque se requieren estudios a largo plazo para confirmar su impacto sostenido en la salud metabólica. [ABSTRACT FROM AUTHOR]
	Copyright of Revista Medica del IMSS is the property of Direccion de Prestaciones Medicas - IMSS and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database:	MedicLatina

Description
Abstract:	Background: Obesity is a highly prevalent disease that significantly impacts quality of life and life expectancy. Over the past decades, bariatric surgery has become the gold standard for treating obesity and its comorbidities. In 2006, Santoro et al. described the technique of intestinal transit bipartition (ITB) to enhance neuroendocrine mechanisms of weight loss while minimizing nutritional deficiencies common in other procedures. The objective was to describe the first case of ITB performed in a high specialty center as a surgical treatment for obesity. Clinical case: A 44-year-old male patient with grade III obesity and comorbidities, including type 2 diabetes mellitus and obstructive sleep apnea. The patient underwent ITB combined with sleeve gastrectomy. During follow-up, a significant reduction in body weight was observed (%EWL of 94.9% at 6 months), without alterations in biochemical parameters such as albumin, hemoglobin, or vitamin D levels. The procedure was safe, with no surgical or postoperative complications. Conclusion: ITB is a promising surgical technique for the treatment of obesity and its comorbidities, with results comparable to other bariatric procedures. Its neuroendocrine effect favors metabolic control and significant weight loss, while limiting nutritional complications. Initial results highlight its safety and feasibility as a therapeutic alternative, although long-term studies are required to confirm its sustained impact on metabolic health. [ABSTRACT FROM AUTHOR]
ISSN:	04435117
DOI:	10.5281/zenodo.18715482